Skip to main content
Cancer Biotherapy & Radiopharmaceuticals logoLink to Cancer Biotherapy & Radiopharmaceuticals
. 2021 Dec 6;36(10):889. doi: 10.1089/cbr.2014.1698.retract

Retraction of: Ribosomal Protein S15A Augments Human Osteosarcoma Cell Proliferation In Vitro (doi: 10.1089/cbr.2014.1698)

PMCID: PMC8713445  PMID: 34596420

Cancer Biotherapy and Radiopharmaceuticals officially retracts the article entitled, “Ribosomal Protein S15A Augments Human Osteosarcoma Cell Proliferation In Vitro,” by Chen Zhang, Ting Zhang, E Song, Himaya SWA, Xianzhen Chen, and Longpo Zheng, (Cancer Biother Radiopharm 2014;29(10):451–456; doi: 10.1089/cbr.2014.1698) due to incorrectly attributed or identified sequences. Several figures and text within the methods section are strikingly similar to those in other publications1–3 and suggests that same party prepared these papers for entirely different author sets.

The Editor and Publisher of Cancer Biotherapy and Radiopharmaceuticals are committed to preserving the scientific literature and the community it serves.

References

  • 1. Wang Z, Xu D, Gao Y, et al. . Immature colon carcinoma transcript 1 is essential for prostate cancer cell viability and proliferation. Cancer Biother Radiopharm 2015;30(7):278–284; doi: 10.1089/cbr.2014.1728. [DOI] [PubMed] [Google Scholar]
  • 2. Wang H, Wang B, Zhu W, et al. . Lentivirus-mediated knockdown of myosin VI inhibits cell proliferation of breast cancer cell. Cancer Biother Radiopharm 2015;30(8):330–335; doi: 10.1089/cbr.2014.1759. [DOI] [PubMed] [Google Scholar]
  • 3. Zhao S, Chen X, Wan M, et al. . Tectonic 1 is a key regulator of cell proliferation in pancreatic cancer. Cancer Biother Radiopharm 2016;31(1):7–13; doi: 10.1089/cbr.2014.1778. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Biotherapy & Radiopharmaceuticals are provided here courtesy of Mary Ann Liebert, Inc.

RESOURCES